WANBURY.NS

Wanbury Limited [WANBURY.NS] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

WANBURY.NS Stock Summary

Top 10 Correlated ETFs

WANBURY.NS

Top 10 Correlated Stocks

WANBURY.NS

In the News

WANBURY.NS Financial details

Company Rating
-
Market Cap
5.03B
Income
233.39M
Revenue
5.69B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
1.58K
Optionable
No
Shortable
Yes
Earnings
07 Jun 2024
P/E
43.79
Forward P/E
-
PEG
-6.1
P/S
0.78
P/B
-19.26
P/C
-
P/FCF
-
Quick Ratio
0.35
Current Ratio
0.61
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
7.13
EPS next Y
-
EPS next Q
-
EPS this Y
-112.57%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-21.22%
Revenue last 5Y
5.25%
Revenue Q/Q
0.72%
EPS Q/Q
39.56%
-
-
-
-
SMA20
9.47%
SMA50
16.44%
SMA100
7.34%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
-34%
ROC
0.41%
Gross Margin
43%
Oper. Margin
7%
Profit Margin
2%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
33.6-179.35
52W High
+32.3%
52W Low
+617.64%
RSI
45.55
Rel Volume
1.1
Avg Volume
101.95K
Volume
112.56K
Perf Week
-12.43%
Perf Month
16.26%
Perf Quarter
-1.86%
Perf Half Y
6.22%
-
-
-
-
Beta
0.4
-
-
Volatility
15.78%, 18.05%
Prev Close
-3.11%
Price
236.82
Change
-7.43%

Something similar

Top by Market Cap
BRYN.DE
META
VOO
DHR-PB
LLY.DE
Top Correlated ETFs
ICICIB22.NS
Top Correlated Stocks
JKPAPER.NS
SURYAROSNI.NS
BIRLACABLE.NS
KICL.NS
LAOPALA.NS
Similar Market Cap
TKAMY
SSABBH.HE
PUM.DE
0HYI.L
TWNK

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 101.95K
  • Market Capitalization 5.03B
  • Employee 1.58K
  • CEO Mr. K. Chandran
  • Headquarters Navi Mumbai,IN
  • IPO Date 2007-01-29
  • Website https://www.wanbury.com

Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India. The company offers formulations for gynecology, orthopedics, heamatinics, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner purposes approximately under 70 brands. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive therapeutic areas. Wanbury Limited also exports its products. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India.